Sentence examples for trial definition from inspiring English sources

Four types of stent thrombosis were evaluated: "any" stent thrombosis (based on the trial definition of stent thrombosis), "definite" or "probable" stent thrombosis as defined by the Academic Research Consortium, 13 "definite" stent thrombosis as defined by the Academic Research Consortium, and very late stent thrombosis (stent thrombosis >12 months).

For example, it is clear from the in-depth interviews that, as the trial progressed and participants became familiar with the trial definition of a sex act, the meaning of the questions about sex acts changed for them, while the wording of the CRF questions (and their meaning for the trialists) remained the same.

In our analysis we elected to use the trial definition where this study's composite was not reported.

Their definitions of success were broader than the trial definition and included quitting for longer than in previous attempts and cutting down cigarette consumption.

Low cardiac output syndrome (LCOS) was defined as a decrease in cardiac output due to transient myocardial dysfunction and included cardiogenic shock as per the IABP shock trial definition [ 7].

Three types of stent thrombosis were evaluated: Academic Research Consortium (ARC) defined definite stent thrombosis (primary), ARC defined "definite" or "probable" stent thrombosis, and "any" stent thrombosis (on the basis of the trial definition of stent thrombosis) (secondary).

The individual trial definitions of outcomes are outlined in supplementary table D. The primary analysis compared each treatment group against the unfractionated heparin plus GpIIb/IIIa inhibitor group, which was chosen as the reference group.

We classified stent thrombosis as definite/probable, definite, late (between 30 days and one year after percutaneous coronary intervention), and very late (>one year after percutaneous coronary intervention) according to criteria from the Academic Research Consortium. 13 For major bleeding, trial definitions were applied.

We also gathered information about the frequency of the following adverse effects as defined by individual trials' definitions: Worsening renal function, symptomatic hypotension, hyperkalemia, cough, rash, angioedema and permanent discontinuation of study medication.

In clinical trials, definitions of severity are generally based on cut-points for patient-reported pain, function, and global assessments.

Nevertheless, in the above mentioned trials definitions of cardiac and ischemic disease were not consistently defined, follow-up was short (<10 years), and risk factors for coronary disease (including lipid profiles) were not systematically documented.